Exact Mass: 498.3431

Neurosporaxanthin

C35H46O2 (498.3498)

D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

PoricoicacidA

C31H46O5 (498.3345)

Poricoic acid A is a tricyclic triterpenoid isolated from Poria cocos. It has a role as a fungal metabolite. It is a tricyclic triterpenoid, a dicarboxylic acid and a secondary alcohol. Poricoic acid A is a natural product found in Phellodendron amurense and Wolfiporia cocos with data available. Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2]. Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2].

Poricoic

C31H46O5 (498.3345)

Poricoic acid A is a tricyclic triterpenoid isolated from Poria cocos. It has a role as a fungal metabolite. It is a tricyclic triterpenoid, a dicarboxylic acid and a secondary alcohol. Poricoic acid A is a natural product found in Phellodendron amurense and Wolfiporia cocos with data available. A tricyclic triterpenoid isolated from Poria cocos. Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2]. Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2].

Sootepin A

C31H46O5 (498.3345)

6,7-Dehydroporicoic acid H

C31H46O5 (498.3345)

Garsubellin B

C31H46O5 (498.3345)

Garsubellin E

C31H46O5 (498.3345)

25-Hydroxyporicoic acid C

C31H46O5 (498.3345)

Hyperibone J

C31H46O5 (498.3345)

poricoic acid F

C31H46O5 (498.3345)

Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2]. Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2].

Poricoic acid AM

C31H46O5 (498.3345)

15-Hydroxy-14,15-dihydro-isoborreverin|7,7,9-trimethyl-11-(2-methylamino-ethyl)-6-[3-(2-methylamino-ethyl)-1H-indol-2-yl]-6a,7,8,9,10,10a-hexahydro-6H-isoindolo[2,1-a]indol-9-ol|Hydroxy-15-dihydro-14,15-isoborreverin

C32H42N4O (498.3358)

(3beta,4alpha)-4-hydroxy-3,23-(isopropylidenedioxy)-24,30-dinoroleana-12,20(29)-dien-28-oic acid

C31H46O5 (498.3345)

honulactone B

C31H46O5 (498.3345)

3beta-Benzoyloxy-ergosta-5,7,22t,24(28)-tetraen|3beta-benzoyloxy-ergosta-5,7,22t,24(28)-tetraene|3beta-Benzoyloxyergosta-5,7,22,24(28)-tetraen

C35H46O2 (498.3498)

2-(1-Hydroxy-1,5-dimethyl-4-hexenyl)-2,3-dihydro-5-methyl-7-(2-methylpropanoyl)-5,7-diprenylbenzofuran-4,6(5H,7H)-dione

C31H46O5 (498.3345)

10-[3-(2-methylamino-ethyl)-indol-2-yl]-1,1,3,13-tetramethyl-2,3,4,4a,10,10a-hexahydro-1H,5H-4b,9b-[1]azapropano-indeno[1,2-b]indol-3-ol|15-Hydroxy-14,15-dihydroborrererin|Hydroxy-15 dihydro-14,15 borreverin

C32H42N4O (498.3358)

petuniasterone M

C31H46O5 (498.3345)

29-hydroxypolyporenic acid C

C31H46O5 (498.3345)

viburnudienone B1 methyl ester

C31H46O5 (498.3345)

(20xi)-16alpha,25-dihydroxy-3-oxo-24-methyllanosta-7,9(11),24(241)-trien-21-oic acid|16alpha,25-dihydroxydehydroeburiconic acid

C31H46O5 (498.3345)

6alpha-Hydroxy-polyporensaeure C

C31H46O5 (498.3345)

9,11-Anhydrofusidic acid

C31H46O5 (498.3345)

2-(1-Hydroxy-1,5-dimethyl-4-hexenyl)-2,3-dihydro-7-methyl-5-(2-methylpropanoyl)-5,7-diprenylbenzofuran-4,6(5H,7H)-dione

C31H46O5 (498.3345)

3beta,6alpha-diacetoxy-5alpha-cholesta-9(11),20(22)-dien-23-one

C31H46O5 (498.3345)

kuguacin I

C31H46O5 (498.3345)

dysolenticin I

C31H46O5 (498.3345)

A tetracyclic triterpenoid isolated from Dysoxylum lenticellatum.

carinatin E

C31H46O5 (498.3345)

C31H46O5

C31H46O5 (498.3345)

schiglausin G

C31H46O5 (498.3345)

1,2-dehydro-2,3-seco-2,24-epoxy-D:A-friedooleane-29-oic acid methyl ester|cassinolide

C31H46O5 (498.3345)

(22R)-18,22-diacetoxy-cholesta-1,4-dien-3-one

C31H46O5 (498.3345)

(12beta,22R)-12,22-diacetoxy-cholesta-1,4-dien-3-one

C31H46O5 (498.3345)

2alpha,3alpha-di-O-carbonyl-2alpha,3alpha-dihydroxytaraxer-14-en-28-oic acid

C31H46O5 (498.3345)

7-deacetylbruceajavanin B

C31H46O5 (498.3345)

methyl 11alpha-hydroxy-3,7-dioxo-5alpha-lanosta-8,24(E)-dien-26-oate

C31H46O5 (498.3345)

(2R)-2-[(2R,3R,3aR,6S,7S,9bR)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-prop-1-en-2-yl-1,2,3,4,7,8-hexahydrocyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

2alpha-hydroxy-3beta-methoxy-6-oxo-13alpha,14beta,17alpha-lanosta-7,24-dien-21,16beta-olide

C31H46O5 (498.3345)

poricoic acid BM

C31H46O5 (498.3345)

Liquorsaeure-methylester

C31H46O5 (498.3345)

Leptolstatin

C31H46O5 (498.3345)

3beta,6alpha-Diacetoxy-5alpha-cholesta-9(11),24-dien-23-on

C31H46O5 (498.3345)

2-Demethylvitamin K2(25)

C35H46O2 (498.3498)

Me ether-11-Hydroxy-3,21-dioxo-12-oleanen-28-oic acid|Propapyriogenin A1

C31H46O5 (498.3345)

3,4-secotirucalla-23-oxo-4(28),7,24-trien-21-al-3,21-dioic acid 21-methyl ester

C31H46O5 (498.3345)

3,5-dihidroxy-4-<<(1R*,2S*,5S*)-2-hydroxy-2-methyl-5-(1-methylethenyl)cyclopentyl>methyl>-2-(3-methylbutanoyl)-6,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one|3,5-dihidroxy-4-{[(1R*,2S*,5S*)-2-hydroxy-2-methyl-5-(1-methylethenyl)cyclopentyl]methyl}-2-(3-methylbutanoyl)-6,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one|3,5-dihydroxy-4-{[(1R,2S,5S)-2-hydroxy-2-methyl-5-(1-methylethenyl)cyclopentyl]methyl}-2-(3-methylbutanoyl)-6,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one

C31H46O5 (498.3345)

11alpha-Hydroxy-3,7-dioxo-5alpha-lanosta-8,24-diene-26-oic acid methyl ester

C31H46O5 (498.3345)

Apo-4-lycopenoic acid

C35H46O2 (498.3498)

AIDS-113410

C31H46O5 (498.3345)

Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2]. Poricoic acid A, isolated from Poria cocos, possesses anti-tumor activity[1]. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis[2].

(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-2,6,10,15,19,23,27-heptamethyloctacosa-2,4,6,8,10,12,14,16,18,20,22,26-dodecaenoic acid

C35H46O2 (498.3498)

[3-carboxy-2-[(5Z,8E,13E)-11,12,15-trihydroxyicosa-5,8,13-trienoyl]oxypropyl]-trimethylazanium

C27H48NO7+ (498.3431)

[3-carboxy-2-[7-[3-hydroxy-2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoyloxy]propyl]-trimethylazanium

C27H48NO7+ (498.3431)

[3-carboxy-2-[7-[5-hydroxy-2-[(E)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]heptanoyloxy]propyl]-trimethylazanium

C27H48NO7+ (498.3431)

[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-hydroxypropyl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C31H46O5 (498.3345)

[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-hydroxypropyl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C31H46O5 (498.3345)

ST 28:0;O2;S

C28H50O5S (498.3379)

(2r)-2-[(1r,2r,3as,3bs,7r,9ar,11ar)-2,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-4-oxo-1h,2h,3h,3bh,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

7-(acetyloxy)-9a,11a-dimethyl-1-(6-methyl-4-oxohept-2-en-2-yl)-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-5-yl acetate

C31H46O5 (498.3345)

methyl 2-methyl-2-[(1r,5s,6r,9r,10r,13s,14r,16r)-5,9,10-trimethyl-13-[(2e)-6-methyl-4-oxohepta-2,5-dien-2-yl]-3-oxo-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadecan-6-yl]propanoate

C31H46O5 (498.3345)

(2z,6r)-6-[(2r,4as,4br,7s,8s,9ar)-8-(2-carboxyethyl)-9a-methoxy-4a,8-dimethyl-1-methylidene-7-(prop-1-en-2-yl)-3,4,4b,5,6,7-hexahydro-2h-fluoren-2-yl]-2-methylhept-2-enoic acid

C31H46O5 (498.3345)

16α, 25-dihydroxydehydroeburicoic acid

C31H46O5 (498.3345)

{"Ingredient_id": "HBIN001797","Ingredient_name": "16\u03b1, 25-dihydroxydehydroeburicoic acid","Alias": "NA","Ingredient_formula": "C31H46O5","Ingredient_Smile": "CC1(C2CC=C3C(=CCC4(C3(CC(C4C(CCC(=C)C(C)(C)O)C(=O)O)O)C)C)C2(CCC1=O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41113","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

6α-Hydroxypolyporenic acid C

C31H46O5 (498.3345)

{"Ingredient_id": "HBIN012207","Ingredient_name": "6\u03b1-Hydroxypolyporenic acid C","Alias": "NA","Ingredient_formula": "C31H46O5","Ingredient_Smile": "CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CC(C4C3(CCC(=O)C4(C)C)C)O)C)C)O)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35871","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1r,5s,8r,9r,12r,19r)-19-methoxy-5,9,17,17-tetramethyl-8-[(2r)-6-methyl-4-oxohept-5-en-2-yl]-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadecane-3,16-dione

C31H46O5 (498.3345)

2-[6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,7h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

methyl 2-methyl-2-[5,9,10-trimethyl-13-(6-methyl-4-oxohepta-2,5-dien-2-yl)-3-oxo-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadecan-6-yl]propanoate

C31H46O5 (498.3345)

(1r,3r,4r,5s,7r,8s)-8-hydroxy-4,7-dimethyl-1,5-bis(3-methylbut-2-en-1-yl)-4-(4-methylpent-3-en-1-yl)-3-(2-methylpropanoyl)-9-oxatricyclo[5.2.1.0³,⁸]decane-2,10-dione

C31H46O5 (498.3345)

(1s,3br,4r,5ar,9ar,9br,11as)-1-[(2s,3s,5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-methoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C31H46O5 (498.3345)

(1s,3s,8r,10s)-3-(2-hydroxypropan-2-yl)-9,9-dimethyl-6,10-bis(3-methylbut-2-en-1-yl)-8-[(2s)-2-methylbutanoyl]-4-oxatricyclo[6.3.1.0¹,⁵]dodec-5-ene-7,12-dione

C31H46O5 (498.3345)

2,6,10,15,19-pentamethyl-21-(2,6,6-trimethylcyclohex-1-en-1-yl)henicosa-2,4,6,8,10,12,14,16,18,20-decaenoic acid

C35H46O2 (498.3498)

(1s,3s,8r,10s)-3-(2-hydroxypropan-2-yl)-9,9-dimethyl-6,10-bis(3-methylbut-2-en-1-yl)-8-(2-methylbutanoyl)-4-oxatricyclo[6.3.1.0¹,⁵]dodec-5-ene-7,12-dione

C31H46O5 (498.3345)

10,11-dihydroxy-2,4a,6a,6b,8a,9,9,12b-octamethyl-8-oxo-1,3,4,5,6,7,10,11,12,12a-decahydropicene-2-carboxylic acid

C31H46O5 (498.3345)

(2r)-2-[(1r,2s,3r,3ar,5ar,9as,11ar)-2,3-dihydroxy-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

(2's,3s,5as,5br,7ar,8s,11ar,11br,13s,13as)-2',3,5b,11a,13a-pentamethyl-1-oxo-4,5,5a,6,7,7a,9,10,11,11b,12,13-dodecahydro-3h-spiro[chryseno[1,2-c]furan-8,1'-cyclopropan]-13-yl 3-hydroxybutanoate

C31H46O5 (498.3345)

4-hydroxy-3a,6,6,9a,11a-pentamethyl-1-(6-methyl-7-oxohept-5-en-2-yl)-10-oxo-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl formate

C31H46O5 (498.3345)

(2r)-2-[(1r,2r,3ar,5ar,6s,9as,11ar)-2-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

6-(14,19-dihydroxy-3,5,9,11,13,15,17-heptamethyl-12-oxononadeca-1,3,7,9,17-pentaen-1-yl)-5,6-dihydropyran-2-one

C31H46O5 (498.3345)

1-(5-{9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-isopropyl-6-oxooxan-2-yl)ethyl acetate

C31H46O5 (498.3345)

methyl 3-[14-(7-hydroxy-6-methylhept-5-en-2-yl)-11,15-dimethyl-5-methylidene-6-oxo-7-oxapentacyclo[8.7.0.0¹,³.0⁴,⁸.0¹¹,¹⁵]heptadecan-3-yl]propanoate

C31H46O5 (498.3345)

2-[7-ethenyl-2-hydroxy-6-(3-methoxy-3-oxopropyl)-3a,6,9b-trimethyl-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

2-[6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

3-[(3s,3as,5ar,6s,7s,9bs)-3-[(2s)-1-methoxy-6-methyl-1,4-dioxohept-5-en-2-yl]-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,5ah,7h,8h-cyclopenta[a]naphthalen-6-yl]propanoic acid

C31H46O5 (498.3345)

2-[2-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

(10s,12s,15s,16r)-12,14,14-trimethyl-8-[2-(methylamino)ethyl]-16-{3-[2-(methylamino)ethyl]-1h-indol-2-yl}-1-azatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-2,4,6,8-tetraen-12-ol

C32H42N4O (498.3358)

(1r,3as,3bs,4r,9ar,9bs,11ar)-1-[(1s)-1-[(1s,3r,5r)-1-ethyl-5,6,6-trimethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C31H46O5 (498.3345)

3,5-dihydroxy-4-[(1r,2r,5s)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclohexyl]-6,6-bis(3-methylbut-2-en-1-yl)-2-(2-methylbutanoyl)cyclohexa-2,4-dien-1-one

C31H46O5 (498.3345)

(2r)-2-[(1r,2r,3ar,5s,5ar,9as,11ar)-2,5-dihydroxy-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

(4as,4br,6ar,6bs,8as,12as,14ar,14br,16as)-4a-hydroxy-2,2,6a,6b,14b-pentamethyl-11-methylidene-4h,4bh,5h,6h,7h,8h,9h,10h,12h,12ah,14h,14ah,15h,16h,16ah-piceno[3,4-d][1,3]dioxine-8a-carboxylic acid

C31H46O5 (498.3345)

4a-hydroxy-2,2,6a,6b,14b-pentamethyl-11-methylidene-4h,4bh,5h,6h,7h,8h,9h,10h,12h,12ah,14h,14ah,15h,16h,16ah-piceno[3,4-d][1,3]dioxine-8a-carboxylic acid

C31H46O5 (498.3345)

(2r,4ar,6as,6br,8ar,10s,11s,12ar,12br)-10,11-dihydroxy-2,4a,6a,6b,8a,9,9,12b-octamethyl-8-oxo-1,3,4,5,6,7,10,11,12,12a-decahydropicene-2-carboxylic acid

C31H46O5 (498.3345)

(2s)-2-[(3r,3ar,6s,7s,9br)-6-(2-carboxyethyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-hydroxy-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

(2r)-2-[(2r,3r,3ar,6s,7s,9br)-2-hydroxy-6-(3-methoxy-3-oxopropyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methylhept-5-enoic acid

C31H46O5 (498.3345)

2-[(3r,3ar,6s,7s,9br)-6-(2-carboxyethyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-hydroxy-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

(2s,5s,7s)-2-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-5-methyl-5,7-bis(3-methylbut-2-en-1-yl)-7-(2-methylpropanoyl)-2,3-dihydro-1-benzofuran-4,6-dione

C31H46O5 (498.3345)

(2r,4ar,6as,6br,8ar,10s,12r,12ar,12br)-10,12-dihydroxy-2,4a,6a,6b,8a,9,9,12b-octamethyl-8-oxo-1,3,4,5,6,7,10,11,12,12a-decahydropicene-2-carboxylic acid

C31H46O5 (498.3345)

methyl 9-hydroxy-3,4,8,8,12,19,22-heptamethyl-14-oxo-23-oxahexacyclo[18.2.1.0³,¹⁶.0⁴,¹³.0⁷,¹².0¹⁷,²²]tricos-15-ene-19-carboxylate

C31H46O5 (498.3345)

2-[6-(2-carboxyethyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-hydroxy-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

methyl 3-[(1r,3s,4s,8s,10r,11r,14s,15s)-14-[(2s,5e)-7-hydroxy-6-methylhept-5-en-2-yl]-11,15-dimethyl-5-methylidene-6-oxo-7-oxapentacyclo[8.7.0.0¹,³.0⁴,⁸.0¹¹,¹⁵]heptadecan-3-yl]propanoate

C31H46O5 (498.3345)

3,5-dihydroxy-4-{[2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-6,6-bis(3-methylbut-2-en-1-yl)-2-(3-methylbutanoyl)cyclohexa-2,4-dien-1-one

C31H46O5 (498.3345)

(2r)-2-[(2r,3r,3ar,6s,7r,9br)-7-ethenyl-2-hydroxy-6-(3-methoxy-3-oxopropyl)-3a,6,9b-trimethyl-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

2-[(2r,3r,3ar,6s,7s,9br)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,7h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

(6r)-6-[(1e,3z,5r,7e,9e,11r,13s,14r,15s,17e)-14,19-dihydroxy-3,5,9,11,13,15,17-heptamethyl-12-oxononadeca-1,3,7,9,17-pentaen-1-yl]-5,6-dihydropyran-2-one

C31H46O5 (498.3345)

(1s,4r,5r,6r,8r,10s,12s,13s,16r,17s,18s,21r)-18-hydroxy-4,4',6,12,17-pentamethyl-3'-methylidene-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxolane]-17-carboxylic acid

C31H46O5 (498.3345)

(2r)-2-[(1r,2r,3ar,5ar,9as,11ar)-2-hydroxy-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

(1r,3ar,4s,5ar,7s,9as,11ar)-4-hydroxy-3a,6,6,9a,11a-pentamethyl-1-[(2r,5e)-6-methyl-7-oxohept-5-en-2-yl]-10-oxo-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl formate

C31H46O5 (498.3345)

12,14,14-trimethyl-8-[2-(methylamino)ethyl]-16-{3-[2-(methylamino)ethyl]-1h-indol-2-yl}-1-azatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-2,4,6,8-tetraen-12-ol

C32H42N4O (498.3358)

2-(2-hydroxy-6-methylhept-5-en-2-yl)-7-methyl-5,7-bis(3-methylbut-2-en-1-yl)-5-(2-methylpropanoyl)-2,3-dihydro-1-benzofuran-4,6-dione

C31H46O5 (498.3345)

(1r,3as,3bs,5s,5as,7s,9as,11as)-7-(acetyloxy)-9a,11a-dimethyl-1-[(2z)-6-methyl-4-oxohept-2-en-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-5-yl acetate

C31H46O5 (498.3345)

(2r)-2-[(1r,2r,3ar,5ar,9as,11ar)-2-hydroxy-3a,6,6,9a,11a-pentamethyl-4,7-dioxo-1h,2h,3h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

methyl 2-methyl-2-[(1r,5s,6r,9r,10r,13s,14r,16r)-5,9,10-trimethyl-13-[(2z)-6-methyl-4-oxohepta-2,5-dien-2-yl]-3-oxo-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadecan-6-yl]propanoate

C31H46O5 (498.3345)

2-[(2r,3r,3ar,6s,7s,9br)-2-hydroxy-6-(3-methoxy-3-oxopropyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methylhept-5-enoic acid

C31H46O5 (498.3345)

3,5-dihydroxy-4-{[(1r,2s,5s)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl]methyl}-6,6-bis(3-methylbut-2-en-1-yl)-2-(3-methylbutanoyl)cyclohexa-2,4-dien-1-one

C31H46O5 (498.3345)

(1r,4r,8s,10r)-4-(2-hydroxypropan-2-yl)-9,9-dimethyl-1,10-bis(3-methylbut-2-en-1-yl)-8-(2-methylbutanoyl)-3-oxatricyclo[6.3.1.0²,⁶]dodec-2(6)-ene-7,12-dione

C31H46O5 (498.3345)

8-hydroxy-4,7-dimethyl-1,5-bis(3-methylbut-2-en-1-yl)-4-(4-methylpent-3-en-1-yl)-3-(2-methylpropanoyl)-9-oxatricyclo[5.2.1.0³,⁸]decane-2,10-dione

C31H46O5 (498.3345)

(1r,3as,3bs,4r,9ar,9bs,11ar)-1-[(1s)-1-[(3r,5r)-1-ethyl-5,6,6-trimethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl]ethyl]-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C31H46O5 (498.3345)

2-(2-hydroxy-6-methylhept-5-en-2-yl)-5-methyl-5,7-bis(3-methylbut-2-en-1-yl)-7-(2-methylpropanoyl)-2,3-dihydro-1-benzofuran-4,6-dione

C31H46O5 (498.3345)

6-hydroxy-2-{2-hydroxy-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

(1s,9r,10s,12r,15r,16r)-12,14,14,19-tetramethyl-16-{3-[2-(methylamino)ethyl]-1h-indol-2-yl}-8,19-diazapentacyclo[7.7.3.0¹,⁹.0²,⁷.0¹⁰,¹⁵]nonadeca-2,4,6-trien-12-ol

C32H42N4O (498.3358)

1-(1-{1-ethyl-5,6,6-trimethyl-2,7,8-trioxabicyclo[3.2.1]octan-3-yl}ethyl)-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C31H46O5 (498.3345)

2-[(1r,2r,3ar,5ar,9as,11ar)-2-hydroxy-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

(2r)-2-[(3r,3ar,6s,7s,9br)-6-(2-carboxyethyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-hydroxy-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

(2's,3r,5as,5br,7ar,8s,11ar,11br,13s,13as)-2',3,5b,11a,13a-pentamethyl-1-oxo-4,5,5a,6,7,7a,9,10,11,11b,12,13-dodecahydro-3h-spiro[chryseno[1,2-c]furan-8,1'-cyclopropan]-13-yl 3-hydroxybutanoate

C31H46O5 (498.3345)

(12e,14e,16e,18e,20e)-2,6,10,15,19-pentamethyl-21-(2,6,6-trimethylcyclohex-1-en-1-yl)henicosa-2,4,6,8,10,12,14,16,18,20-decaenoic acid

C35H46O2 (498.3498)

(2s,5r,7s)-2-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-7-methyl-5,7-bis(3-methylbut-2-en-1-yl)-5-(2-methylpropanoyl)-2,3-dihydro-1-benzofuran-4,6-dione

C31H46O5 (498.3345)

methyl 3-[(1s,3r,4r,8r,10s,11s,14r,15r)-14-[(2r,5e)-7-hydroxy-6-methylhept-5-en-2-yl]-11,15-dimethyl-5-methylidene-6-oxo-7-oxapentacyclo[8.7.0.0¹,³.0⁴,⁸.0¹¹,¹⁵]heptadecan-3-yl]propanoate

C31H46O5 (498.3345)

3-[3-(1-methoxy-6-methyl-1,4-dioxohept-5-en-2-yl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,5ah,7h,8h-cyclopenta[a]naphthalen-6-yl]propanoic acid

C31H46O5 (498.3345)

(2r)-2-[(2r,3r,3ar,6s,7s,9br)-6-(2-carboxyethyl)-2-hydroxy-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,7h-cyclopenta[a]naphthalen-3-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O5 (498.3345)

2-[2-hydroxy-6-(3-methoxy-3-oxopropyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,7h,8h-cyclopenta[a]naphthalen-3-yl]-6-methylhept-5-enoic acid

C31H46O5 (498.3345)

10,12-dihydroxy-2,4a,6a,6b,8a,9,9,12b-octamethyl-8-oxo-1,3,4,5,6,7,10,11,12,12a-decahydropicene-2-carboxylic acid

C31H46O5 (498.3345)

12,14,14,19-tetramethyl-16-{3-[2-(methylamino)ethyl]-1h-indol-2-yl}-8,19-diazapentacyclo[7.7.3.0¹,⁹.0²,⁷.0¹⁰,¹⁵]nonadeca-2,4,6-trien-12-ol

C32H42N4O (498.3358)

(1s,4r,8s,10r)-4-(2-hydroxypropan-2-yl)-9,9-dimethyl-1,10-bis(3-methylbut-2-en-1-yl)-8-[(2s)-2-methylbutanoyl]-3-oxatricyclo[6.3.1.0²,⁶]dodec-2(6)-ene-7,12-dione

C31H46O5 (498.3345)

methyl (1r,3s,4r,7s,9s,12s,13r,17s,19r,20r,22s)-9-hydroxy-3,4,8,8,12,19,22-heptamethyl-14-oxo-23-oxahexacyclo[18.2.1.0³,¹⁶.0⁴,¹³.0⁷,¹².0¹⁷,²²]tricos-15-ene-19-carboxylate

C31H46O5 (498.3345)